Serum 8-OHdG and HIF-1? levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?

Basit Öğe Kaydı
dc.contributor.authorHarman, Ece
dc.contributor.authorErdoğan, Mehmet
dc.contributor.authorBiray, C
dc.contributor.authorDodurga, Y
dc.contributor.authorKaradeniz, Muammer
dc.contributor.authorGündüz, Cumhur
dc.contributor.authorHarman, Mustafa
dc.date.accessioned2019-12-23T14:37:27Z
dc.date.available2019-12-23T14:37:27Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstract…en_US
dc.identifier.endpage7en_US
dc.identifier.issue.en_US
dc.identifier.startpage51en_US
dc.identifier.urihttps://hdl.handle.net/11454/57133
dc.identifier.volume17en_US
dc.language.isoenen_US
dc.relation.journalContemp Oncol (Pozn).en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US]
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleSerum 8-OHdG and HIF-1? levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Öksüz Yayınlar